The medtech segment achieved operational revenue growth of 4.4% despite ongoing weaknesses in the Chinese market. Notably, ...
Johnson & Johnson (NYSE: JNJ) (the “Company”) announced that its subsidiary, Red River Talc LLC (“Red River”), filed a ...
In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Johnson & Johnson (JNJ – Research ...
There is more to the comparison, and in the sections below, we discuss why we think Disney will outperform J&J in the next ...
Baltimore settled with opioid manufacturer Johnson & Johnson on the eve of its trial against that company and two ...
In a report released today, Joanne Wuensch from Citi reiterated a Buy rating on Johnson & Johnson (JNJ – Research Report). The ...
Johnson & Johnson said the Food and Drug Administration approved ... of care chemotherapy for patients with certain conditions, the New Jersey healthcare company said. The approval is based on ...
SINGAPORE, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Johnson & Johnson (J&J), a leading healthcare company, announced its 50th anniversary in Singapore. Guided by Our Credo to put the needs and well ...
The city spent "$100 million for a walkie-talkie on a pole, and the reason why they said we needed it was to reduce gun ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Johnson & Johnson (JNJ – Research ...